GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2022

GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Expensive Performer

2788.7000 67.20 (2.47%)

NSE May 13, 2025 15:31 PM

45.17% Gain from 52W Low

Volume: 195.3K

GlaxoSmithKline Pharmaceuticals Ltd.

25 Jul 2022

2788.70

2.47%

Result

GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Unaudited (Standalone And Consolidated) Financial Results For The First Quarter …

BSE India

Unaudited (Standalone and Consolidated) financial results for the first quarter ended 30th June 2022

More from GlaxoSmithKline Pharmaceuticals Ltd.

All Rapid Results

Recommended

Five stocks to buy from analysts this week - May 13, 2025

The Baseline | 13 May 2025, 05:09PM

Market closes lower, Hero MotoCorp's Q4 net profit grows 6.4% YoY to Rs 1,080.9 crore

Trendlyne Marketwatch | 13 May 2025, 03:56PM

Which stocks did superstar investors buy in Q4FY25?

The Baseline | 12 May 2025, 04:25PM